Skip to main content
Clinical Trials/CTRI/2021/07/034759
CTRI/2021/07/034759Not yet recruitingPhase 3

Effectiveness Of Adjuvant HDtDCS On Functional Connectivity On Cognitive And Negative Symptoms Of Schizophrenia : A Controlled fMRI Study

Central Institute Of Psychiatry0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Diagnosis of Schizophrenia using Diagnostic Criteria for Research (DCR) of International Classification of Disease-10th edition (ICD-10, World Health Organization,1992)
  • 2.Duration of illness to be more than or equal to two years.
  • 3.Age between 18- 60 years of either sex
  • 4.The Positive and Negative Syndrome Scale for Schizophrenia (PANSS) negative symptoms score of more than 15
  • 5.Scale for Assessment of Negative Symptoms (SANS) score more than 20
  • 6.Right-handed
  • 7.Educated upto class VIII or above
  • 8.Patients giving written informed consent.

Exclusion Criteria

  • 1.Presence of co-morbid neurological or other psychiatric disorder(s).
  • 2.Patient with co morbid substance dependence, except nicotine and caffeine.
  • 3.Having any metallic implants/parts in body
  • 4.Subjects who have received ECT in past 6 months.
  • 5.Colour blind

Investigators

Similar Trials

Effectiveness Of HDtDCS In Cognitive And... | Clinical Trial